Gene variants predict treatment success for alcoholism medication – 2
Narrator: This is NIH Health Matters. Iím Joe Balintfy. Genetic analysis points researchers towards a better treatment for alcoholism. Dr. Raye Litten with the National Institute on Alcohol Abuse and Alcoholism explains.
Litten: To be able to identify patients who respond say to a medication and perhaps even identify those who may have an adverse reaction will enable clinicians to administer the drug in a more efficient, effective and safer manner.
Narrator: Researchers have found that an experimental medication results in reduced drinking, especially in people with certain gene variants. This means genetic screening could help target or personalize treatments for alcohol dependence. For more about this study, visit www.niaaa.nih.gov. Health Matters is produced by the National Institutes of Health, part of the U.S. Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.